Cutler Group LLC / CA - PROTEOSTASIS THERAPEUTICS IN ownership

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$4,000
-20.0%
3,900
-4.9%
0.00%
Q2 2020$5,000
+25.0%
4,1000.0%0.00%
Q1 2020$4,000
-75.0%
4,100
-64.3%
0.00%
-100.0%
Q4 2019$16,000
+433.3%
11,500
+185.5%
0.00%
Q3 2019$3,0000.0%4,028
-21.5%
0.00%
Q2 2019$3,000
-90.9%
5,128
-76.8%
0.00%
-100.0%
Q1 2019$33,000
+175.0%
22,128
+26.6%
0.00%
Q4 2018$12,000
-33.3%
17,476
+94.2%
0.00%
-100.0%
Q3 2018$18,000
+5.9%
9,000
-28.6%
0.00%
+100.0%
Q2 2018$17,000
-63.0%
12,600
-53.0%
0.00%
-75.0%
Q1 2018$46,00026,8000.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 3,804,027$17,803,0002.95%
HARBOURVEST PARTNERS LLC 440,627$2,062,0000.89%
NEA Management Company, LLC 3,556,778$16,646,0000.61%
Rock Springs Capital Management LP 450,000$2,106,0000.11%
Bain Capital Public Equity Management, LLC 263,498$1,233,0000.07%
ELEMENT CAPITAL MANAGEMENT LLC 65,973$309,0000.06%
Hillhouse Capital Management 865,923$4,053,0000.06%
SABBY MANAGEMENT, LLC 125,151$586,0000.04%
Marshall Wace North America L.P. 684,124$3,421,0000.02%
FNY Partners Fund LP 20,127$94,0000.02%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders